{'fraction_non_alphanumeric': 0.032857142857142856, 'fraction_numerical': 0.018571428571428572, 'mean_word_length': 5.095652173913043, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Asherson's syndrome of the catastrophic antiphospholipid antibodies.

Ronald Asherson died in May 2008. Born in South Africa, he studied medicine in Cape Town and then did one of his post-doctorates with Graham Hughes (“Hughes syndrome”) in London. His main claim to fame is the description of the catastrophic antiphospholipid syndrome (cAPS)1–11 (Figure 1 and 2). He delineated the clinical characteristics of the condition, helped determine the diagnostic criteria, indicated the preferred therapy, and eventually reported on its prognosis.

Long before his description of cAPS Ron showed a great desire for knowledge. He was born in Cape Town in 1934, and qualified in Medicine at the University…